Drug
VX-993 clinical trials
Also written VX-993.
- studies test it
- 9
- open now
- 1
- in phase 3
- 0
- first study started
- 2022
Keep track of what changes. Save the VX-993 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
Studies by the year they started
9 studies that test it; most in 2024 (8)
| Year | Studies |
|---|---|
| 2022 | 1 |
| 2024 | 8 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 7
- Phase 2
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 9 · Other 0
Often tested with
Tested in the same studies.
VX-150 (1) · Suzetrigine (1) · Metformin (1) · Gemfibrozil (1) · Itraconazole (1) · Midazolam (1)
Studies
Open first, then newest update. How each study uses VX-993 is read from its arms, and is right about nine times in ten.
Testing it · 9
- Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral NeuropathyRecruitingPhase 2Vertex Pharmaceuticals IncorporatedNCT06619860Written as VX-993
- A Study Evaluating Efficacy and Safety of VX-993 for Acute Pain After a BunionectomyCompletedPhase 2Vertex Pharmaceuticals IncorporatedNCT06619847Written as VX-993
- A Microneurography Study of NaV1.8 Inhibition in Healthy AdultsCompletedPhase 1Vertex Pharmaceuticals IncorporatedNCT06420765Written as VX-993
- A Phase 1 Dose Escalation Study of Intravenous VX-993 in Healthy AdultsCompletedPhase 1Vertex Pharmaceuticals IncorporatedNCT06394167Written as VX-993
- Evaluation of the Pharmacokinetic Drug-drug Interactions Between VX-993 and Metformin in Healthy AdultsCompletedPhase 1Vertex Pharmaceuticals IncorporatedNCT06523595Written as VX-993
- A Study to Evaluate the Relative Bioavailability and Food Effect of a New Tablet Formulation of VX-993CompletedPhase 1Vertex Pharmaceuticals IncorporatedNCT06508762Written as VX-993
- A Phase 1, Open-label Study Evaluating the Pharmacokinetics and Drug-drug Interaction of VX-993 in Healthy AdultsCompletedPhase 1Vertex Pharmaceuticals IncorporatedNCT06392659Written as VX-993
- A Phase 1 Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics, of VX-993CompletedPhase 1Vertex Pharmaceuticals IncorporatedNCT06226454Written as VX-993
- A Phase 1 Dose Escalation Study of VX-993 in Healthy ParticipantsCompletedPhase 1Vertex Pharmaceuticals IncorporatedNCT05653323Written as VX-993